This post provides a reminder of the importance of healthy scepticism in a world where technologies and companies are founded on little more than hype. The revelation that scientists have been making the same predictions about the potential for predictive medicine for the last 100 years is particularly sobering.
I believe, however, that hype has a place and is probably necessary – in tech and biotech.
The promise of huge outsized rewards for present risk has enabled companies to be funded, new technologies to be commercialised and, ultimately, technological progress. While the promise of technologies like CRISPR Cas9 may not be realised in full, these technologies (and countless others) have, to a certain extent, been made possible by hype.
- Investing With Us
Growth EIS - Investor
Invest in the future of UK technology
Growth EIS - Adviser
Build a portfolio of shares in the future of UK technology
Co-Investor Circle
Invest directly into single companies.
Family Offices
Co-Investing With Oxford Capital
More Information:
- Seeking Investment
Backing Founders
Investing in companies for long-term growth.
More Information:
- About Us
About Us
Learn more about us
Our Investment Approach
Find our more about our approach to investment.
Our Portfolio
Browse our portfolio
Our Team
Meet our team
FAQs
See our frequently asked questions
- Resources
Introduction to EIS
Learn more
EIS Loss Relief Guide
Learn more
EIS Income Tax Relief
Learn more
EIS vs VCTs
Learn more
Is EIS a good investment?
Learn More
Are EIS Tax Free?
Learn More